Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.40 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16866042 | 1.00 | ATM (0.70) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL11481011 | 0.88 | ATM (0.50) | ATMHCAR2MAPTNPSR1RAB9A | |
| Ethylenediamine SCHEMBL28074917 | 0.86 | ATM (0.87) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL15607678 | 0.85 | ATM (0.66) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL690841 | 0.84 | ATM (0.76) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL9561881 | 0.84 | ATM (0.76) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL690840 | 0.84 | ATM (0.76) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL269917 | 0.83 | ATM (1.00) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL28154 | 0.83 | ATM (1.00) | ATMHCAR2MAPTNPSR1RAB9A | |
| SCHEMBL28153 | 0.83 | ATM (1.00) | ATMHCAR2MAPTNPSR1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2702035-B1 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | COUNCIL SCIENT IND RES (IN) | 2018-03-07 | — | — | EP | claimed |
| US-9199913-B2 | Process for continous flow synthesis of beta-amino crotonate | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | claimed |
| EP-2702035-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | Council of Scientific & Industrial Research (IN) | 2014-03-05 | — | — | EP | claimed |
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-02-13 | — | — | US | claimed |
| WO-2012147103-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF β-ΑΜΙΝΟ CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-11-01 | — | — | WO | claimed |
| EP-2702035-B1 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | COUNCIL SCIENT IND RES (IN) | 2018-03-07 | — | — | EP | disclosed |
| US-9376372-B2 | Process for producing amine compounds | MONASH UNIVERSITY (AU) | 2016-06-28 | — | — | US | disclosed |
| US-9199913-B2 | Process for continous flow synthesis of beta-amino crotonate | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | disclosed |
| US-20150183724-A1 | PROCESS FOR PRODUCING AMINE COMPOUNDS | MONASH UNIVERSITY (AU) | 2015-07-02 | — | — | US | disclosed |
| EP-2702035-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE | Council of Scientific & Industrial Research (IN) | 2014-03-05 | — | — | EP | disclosed |
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-02-13 | — | — | US | disclosed |
| WO-2014005196-A1 | PROCESSES FOR PRODUCING AMINE COMPOUNDS | MONASH UNIVERSITY (AU) | 2014-01-09 | — | — | WO | disclosed |
| WO-2012147103-A2 | PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF β-ΑΜΙΝΟ CROTONATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183724-A1 | PROCESS FOR PRODUCING AMINE COMPOUNDS | DDC, SRM, DAO | ATM 1215/4885HCAR2 1975/4885MAPT 272/4885 |
| US-20140046090-A1 | PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE | CACNA1C, CACNB3, CROCC | ATM 4369/4885HCAR2 359/4885MAPT 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.